ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SRZN vs ENTX // RETURN ON INVESTED CAPITAL (ROIC)

Surrozen Inc. (NASDAQ) VS. Entera Bio Ltd. (NASDAQ) • 15-METRIC TALLY: SRZN 0 — ENTX 4
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ENTX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRZN VS. ENTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SRZN ENTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 0.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -33.60% -1.40 ENTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.79% -1.38% -4.41 ENTX /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% -65.00% 0.00 TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.1 59.4 -0.30 ENTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $524.4M $542.6M -$18.2M ENTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SRZN REV ENTX REV SRZN GROSS % ENTX GROSS % SRZN FCF ENTX FCF
FY 2025 $3.5M $42.0K — 0.0% -$30.4M -$7.5M
FY 2024 $10.7M $181.0K — 5.0% -$17.7M -$6.8M
FY 2023 $0 $0 — — -$40.4M -$7.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRZN // BETA —
ENTX // BETA —